Nanoparticles for the delivery of genes and drugs to human hepatocytes

Tadanori Yamada, Yasushi Iwasaki, Hiroko Tada, Hidehiko Iwabuki, Marinee K L Chuah, Thierry VandenDriessche, Hideki Fukuda, Akihiko Kondo, Masakazu Ueda, Masaharu Seno, Katsuyuki Tanizawa, Shun'ichi Kuroda

Research output: Contribution to journalArticle

209 Citations (Scopus)

Abstract

Hepatitis B virus envelope L particles form hollow nanoparticles displaying a peptide that is indispensable for liver-specific infection by hepatitis B virus in humans. Here we demonstrate the use of L particles for the efficient and specific transfer of a gene or drug into human hepatocytes both in culture and in a mouse xenograft model. In this model, intravenous injection of L particles carrying the gene for green fluorescent protein (GFP) or a fluorescent dye resulted in observable fluorescence only in human hepatocellular carcinomas but not in other human carcinomas or in mouse tissues. When the gene encoding human clotting factor IX was transferred into the xenograft model using L particles, factor IX was produced at levels relevant to the treatment of hemophilia B. The yeast-derived L particle is free of viral genomes, highly specific to human liver cells and able to accommodate drugs as well as genes. These advantages should facilitate targeted delivery of genes and drugs to the human liver.

Original languageEnglish
Pages (from-to)885-890
Number of pages6
JournalNature Biotechnology
Volume21
Issue number8
DOIs
Publication statusPublished - Aug 1 2003

Fingerprint

Nanoparticles
Hepatocytes
Genes
Liver
Factor IX
Pharmaceutical Preparations
Viruses
Heterografts
Hepatitis B virus
Gene encoding
Blood Coagulation Factors
Human engineering
Green Fluorescent Proteins
Fluorescent Dyes
Cell culture
Hemophilia B
Yeast
L Forms
Peptides
Viral Genome

ASJC Scopus subject areas

  • Microbiology

Cite this

Yamada, T., Iwasaki, Y., Tada, H., Iwabuki, H., Chuah, M. K. L., VandenDriessche, T., ... Kuroda, S. (2003). Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nature Biotechnology, 21(8), 885-890. https://doi.org/10.1038/nbt843

Nanoparticles for the delivery of genes and drugs to human hepatocytes. / Yamada, Tadanori; Iwasaki, Yasushi; Tada, Hiroko; Iwabuki, Hidehiko; Chuah, Marinee K L; VandenDriessche, Thierry; Fukuda, Hideki; Kondo, Akihiko; Ueda, Masakazu; Seno, Masaharu; Tanizawa, Katsuyuki; Kuroda, Shun'ichi.

In: Nature Biotechnology, Vol. 21, No. 8, 01.08.2003, p. 885-890.

Research output: Contribution to journalArticle

Yamada, T, Iwasaki, Y, Tada, H, Iwabuki, H, Chuah, MKL, VandenDriessche, T, Fukuda, H, Kondo, A, Ueda, M, Seno, M, Tanizawa, K & Kuroda, S 2003, 'Nanoparticles for the delivery of genes and drugs to human hepatocytes', Nature Biotechnology, vol. 21, no. 8, pp. 885-890. https://doi.org/10.1038/nbt843
Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MKL, VandenDriessche T et al. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nature Biotechnology. 2003 Aug 1;21(8):885-890. https://doi.org/10.1038/nbt843
Yamada, Tadanori ; Iwasaki, Yasushi ; Tada, Hiroko ; Iwabuki, Hidehiko ; Chuah, Marinee K L ; VandenDriessche, Thierry ; Fukuda, Hideki ; Kondo, Akihiko ; Ueda, Masakazu ; Seno, Masaharu ; Tanizawa, Katsuyuki ; Kuroda, Shun'ichi. / Nanoparticles for the delivery of genes and drugs to human hepatocytes. In: Nature Biotechnology. 2003 ; Vol. 21, No. 8. pp. 885-890.
@article{cd97a5f5370847278f96201a9868dcd9,
title = "Nanoparticles for the delivery of genes and drugs to human hepatocytes",
abstract = "Hepatitis B virus envelope L particles form hollow nanoparticles displaying a peptide that is indispensable for liver-specific infection by hepatitis B virus in humans. Here we demonstrate the use of L particles for the efficient and specific transfer of a gene or drug into human hepatocytes both in culture and in a mouse xenograft model. In this model, intravenous injection of L particles carrying the gene for green fluorescent protein (GFP) or a fluorescent dye resulted in observable fluorescence only in human hepatocellular carcinomas but not in other human carcinomas or in mouse tissues. When the gene encoding human clotting factor IX was transferred into the xenograft model using L particles, factor IX was produced at levels relevant to the treatment of hemophilia B. The yeast-derived L particle is free of viral genomes, highly specific to human liver cells and able to accommodate drugs as well as genes. These advantages should facilitate targeted delivery of genes and drugs to the human liver.",
author = "Tadanori Yamada and Yasushi Iwasaki and Hiroko Tada and Hidehiko Iwabuki and Chuah, {Marinee K L} and Thierry VandenDriessche and Hideki Fukuda and Akihiko Kondo and Masakazu Ueda and Masaharu Seno and Katsuyuki Tanizawa and Shun'ichi Kuroda",
year = "2003",
month = "8",
day = "1",
doi = "10.1038/nbt843",
language = "English",
volume = "21",
pages = "885--890",
journal = "Biotechnology",
issn = "0733-222X",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Nanoparticles for the delivery of genes and drugs to human hepatocytes

AU - Yamada, Tadanori

AU - Iwasaki, Yasushi

AU - Tada, Hiroko

AU - Iwabuki, Hidehiko

AU - Chuah, Marinee K L

AU - VandenDriessche, Thierry

AU - Fukuda, Hideki

AU - Kondo, Akihiko

AU - Ueda, Masakazu

AU - Seno, Masaharu

AU - Tanizawa, Katsuyuki

AU - Kuroda, Shun'ichi

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Hepatitis B virus envelope L particles form hollow nanoparticles displaying a peptide that is indispensable for liver-specific infection by hepatitis B virus in humans. Here we demonstrate the use of L particles for the efficient and specific transfer of a gene or drug into human hepatocytes both in culture and in a mouse xenograft model. In this model, intravenous injection of L particles carrying the gene for green fluorescent protein (GFP) or a fluorescent dye resulted in observable fluorescence only in human hepatocellular carcinomas but not in other human carcinomas or in mouse tissues. When the gene encoding human clotting factor IX was transferred into the xenograft model using L particles, factor IX was produced at levels relevant to the treatment of hemophilia B. The yeast-derived L particle is free of viral genomes, highly specific to human liver cells and able to accommodate drugs as well as genes. These advantages should facilitate targeted delivery of genes and drugs to the human liver.

AB - Hepatitis B virus envelope L particles form hollow nanoparticles displaying a peptide that is indispensable for liver-specific infection by hepatitis B virus in humans. Here we demonstrate the use of L particles for the efficient and specific transfer of a gene or drug into human hepatocytes both in culture and in a mouse xenograft model. In this model, intravenous injection of L particles carrying the gene for green fluorescent protein (GFP) or a fluorescent dye resulted in observable fluorescence only in human hepatocellular carcinomas but not in other human carcinomas or in mouse tissues. When the gene encoding human clotting factor IX was transferred into the xenograft model using L particles, factor IX was produced at levels relevant to the treatment of hemophilia B. The yeast-derived L particle is free of viral genomes, highly specific to human liver cells and able to accommodate drugs as well as genes. These advantages should facilitate targeted delivery of genes and drugs to the human liver.

UR - http://www.scopus.com/inward/record.url?scp=12444252075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444252075&partnerID=8YFLogxK

U2 - 10.1038/nbt843

DO - 10.1038/nbt843

M3 - Article

C2 - 12833071

AN - SCOPUS:12444252075

VL - 21

SP - 885

EP - 890

JO - Biotechnology

JF - Biotechnology

SN - 0733-222X

IS - 8

ER -